Accession Number: | 0000899243-21-031275 |
Date: | 2021-08-02 |
Issuer: | MAGENTA THERAPEUTICS, INC. (MGTA) |
Original Submission Date: |
OLSON LISA
C/O MAGENTA THERAPEUTICS, INC.
100 TECHNOLOGY SQUARE
CAMBRIDGE, MA 02139
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 7.11 | 2021-08-02 | deemed execution date | A | 12,500 (a) | 2031-08-01 | common stock 12,500 | $7.11 | 12,500 | direct |
ID | footnote |
---|---|
f1 | this option shall vest and become exercisable in 16 equal quarterly installments beginning on august 2, 2021. |